In this webinar, Dr. Lynda Balneaves discusses how individuals living with lymphoma can make safe and informed decisions about complementary therapies, the latest evidence about popular therapies, and where credible and evidence-based information can be found.
Complementary therapies are growing in popularity and use in Canada, particularly among individuals living with lymphoma and other cancers.
In this webinar, Dr. Lynda Balneaves discusses how individuals living with lymphoma can make safe and informed decisions about complementary therapies, the latest evidence about popular therapies, and where credible and evidence-based information can be found. Viewers will be provided with key questions to ask that will help them in making wise decisions about the use of complementary therapies during their lymphoma experience and beyond.
About Dr. Lynda Balneaves
Dr. Lynda Balneaves is an Associate Professor in the Department of Psychiatry and the Leslie Dan Faculty of Pharmacy in the University of Toronto and inaugural Director of the Centre of Integrative Medicine, a collaboration of the Faculty of Medicine and the Leslie Dan Faculty of Pharmacy, University of Toronto, as well as The Scarborough Hospital. She also holds the Kwok Yuen and Betty Ho Chair in Integrative Medicine at the University of Toronto and is a Scientist in the Department of Psychosocial Oncology and Palliative Care at the Princess Margaret Cancer Centre.
For the past 20 years, Dr. Balneaves has focused her research on supporting informed treatment decisions in people interested in using complementary therapies. Since 2007, Dr. Balneaves has been the Principal Investigator of the Complementary Medicine Education and Outcomes (CAMEO) research program, which has developed and evaluated a variety of education and decision support interventions aimed at helping cancer patients and health professionals make evidence-based decisions about complementary therapies
